Obesity is a risk factor for type 2 diabetes and most patients who suffer from the condition are encouraged to lose weight. However, a type of commonly used diabetes drugs can actually increase body fat in people, according to new research published in The Journal of Neuroscience. The body fat increase was associated with a class of type 2 diabetes drugs known as thiazolidinediones, or TZDs. Drugs in this class include Actos (pioglitazone), Actoplus Met (pioglitazone and metformin), Duetact (pioglitazone and glimepride), Avandia (rosiglitazone), Avandamet (rosiglitazone and metformin), and Avandaryl (rosiglitazone and glimepride). The medical community has known for a ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.